首页> 外国专利> METHODS FOR TARGETED ASSESSMENT AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ACUTE EVENTS AND MORTALITY ASSOCIATED THEREWITH

METHODS FOR TARGETED ASSESSMENT AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ACUTE EVENTS AND MORTALITY ASSOCIATED THEREWITH

机译:有针对性地评估和治疗慢性阻塞性肺疾病以及由此引起的急性事件和死亡率

摘要

Provided herein are methods for assessing a disease score of a subject suffering from or suspected to be suffering from chronic obstructive pulmonary disease (COPD) or associated disease mechanisms, wherein the disease score represents COPD activity or a risk of a severe acute COPD event or mortality. The disease score can be used to stratify the subject into a specific risk category and can further inform patient management decisions. The methods can involve determining a biomarker signature including two or more biomarkers associated with COPD or COPD mechanisms. In some cases, the methods include timing of collection of patient samples with respect to acute event or treatment course. Further provided herein are methods for identifying and/or treating subjects having a greater risk of developing COPD exacerbations.
机译:本文提供了用于评估患有或怀疑患有慢性阻塞性肺疾病(COPD)或相关疾病机制的受试者的疾病评分的方法,其中所述疾病评分代表COPD活性或严重急性COPD事件或死亡的风险。疾病评分可用于将受试者分为特定的风险类别,并可进一步告知患者管理决策。该方法可以包括确定生物标志物签名,该生物标志物签名包括与COPD或COPD机制相关的两个或更多个生物标志物。在某些情况下,该方法包括就急性事件或治疗过程收集患者样品的时间安排。本文进一步提供了用于鉴定和/或治疗具有发展为COPD急性发作的更大风险的受试者的方法。

著录项

  • 公开/公告号WO2020081866A1

    专利类型

  • 公开/公告日2020-04-23

    原文格式PDF

  • 申请/专利权人 PROTERIXBIO INC.;

    申请/专利号WO2019US56817

  • 申请日2019-10-17

  • 分类号G01N33/53;G01N33/68;

  • 国家 WO

  • 入库时间 2022-08-21 11:11:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号